Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine-Reference-Cited by-同舟云学术

Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine

Published:2012-12 Issue:52 Volume:30 Page:7461-7468
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Bologa Monica,Kamtchoua Thierry,Hopfer Robert,Sheng Xiaohua,Hicks Bryony,Bixler Garvin,Hou Victor,Pehlic Vildana,Yuan Tao,Gurunathan Sanjay

Funder

Sanofi Pasteur

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. World Health Organization. Acute respiratory infections; 2009 [cited 30.04.12]. Available from: http://www.who.int/vaccine_research/diseases/ari/en/index3.html.

2. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O’Brien;Lancet,2009

3. Immunogenicity of protein therapeutics;De Groot;Trends Immunol,2007

4. The preventable burden of pneumococcal disease in the developing world;Scott;Vaccine,2007

5. The remaining challenge of pneumonia: the leading killer of children;Dagan;Pediatr Infect Dis J,2011

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study;Vaccines;2024-07-23

2. Otitis media: recent advances in otitis media vaccine development and model systems;Frontiers in Microbiology;2024-01-24

3. Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises?;Vaccine;2023-12

4. Recent progress in pneumococcal protein vaccines;Frontiers in Immunology;2023-09-25

5. Development of a bivalent protein-based vaccine candidate against invasive pneumococcal diseases based on novel pneumococcal surface protein A in combination with pneumococcal histidine triad protein D;Frontiers in Immunology;2023-08-23